Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis

Paclitaxel is a first-line microtubule-stabilizing drug in treating prostate cancer. However, most patients develop resistance and experience relapse. Morin (3,5,7,20,40-pentahydroxyflavone) is an anti-tumor flavonoid in a numerous types of cancer cells including breast, ovarian and lung cancers. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin, Jin, Xunbo, Meng, Huilin, Hu, Bo, Zhang, Tao, Yu, Jiang, Chen, Shaoan, Guo, Xudong, Wang, Weiguo, Jiang, Wei, Wang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564610/
https://www.ncbi.nlm.nih.gov/pubmed/28599307
http://dx.doi.org/10.18632/oncotarget.18133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564610/
https://www.ncbi.nlm.nih.gov/pubmed/28599307
http://dx.doi.org/10.18632/oncotarget.18133

Ejemplares similares